Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: A case report and analysis of the literature

Ian J. Cohen*, Batia Stark, Chaim Kaplinsky, Raphael Weitz, Shoshana Matz, Pinchas Lerman, Erica Rakowsky, Ruth Vogel, Rina Zaizov

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

An episode of leukoencephalopathy is reported in a 13-year-old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4-hour infusion of 500 mg/m2 methotrexate and 12 mg intrathecal methotrexate. The leukoencephalopathy, documented clinically and by CT and EEG, cleared after 2350 mg of leucovorin (citrovorum factor, folinic acid) was given in addition to the 135 mg given as part of the therapy. A review of the literature suggests that leukoencephalopathy may be prevented by high doses of leucovorin and can be treated by high doses, if lower doses were used initially. When high dose leucovorin was not used, residual neurological damage is not unusual.

Original languageEnglish
Pages (from-to)79-87
Number of pages9
JournalPediatric Hematology and Oncology
Volume7
Issue number1
DOIs
StatePublished - 1990

Keywords

  • High-dose folinic acid
  • Leukoencephalopathy
  • Methotrexate toxicity

Fingerprint

Dive into the research topics of 'Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: A case report and analysis of the literature'. Together they form a unique fingerprint.

Cite this